Fig. 5From: Lymphoid enhancer-binding factor 1 (LEF-1): a favorable prognostic factor in adult acute myeloid leukemia in Egyptian patientsa Comparison between LEF-1 expression at diagnosis and day 28 after therapy in a group of 12 patients. b Comparison between LEF-1 expression at diagnosis and day 28 after therapy in a group of 7 out 12 patients whom LEF-1 level showed significant decrease at day 28. c Comparison between LEF-1 expression at diagnosis and day 28 after therapy in a group of 5 out 12 patients whom LEF-1 level did not show any significant change at day 28Back to article page